GSK
719 hedge funds and large institutions have $9.69B invested in GSK in 2015 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 289 increasing their positions, 233 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
719
Holders Change
-21
Holders Change %
-2.84%
% of All Funds
19.39%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.3%
New
52
Increased
289
Reduced
233
Closed
64
Calls
$221M
Puts
$218M
Net Calls
+$3.72M
Net Calls Change
+$95.3M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$303M |
| 2 |
D.E. Shaw & Co
New York
|
+$75M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$54.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$41.8M |
| 5 |
Jane Street
New York
|
+$34.6M |
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$456M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$357M |
| 3 |
Barclays
London,
United Kingdom
|
-$172M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$107M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$97.2M |
